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http://dxObjective: The outcome of aortic valve replacement for patients with low gradient severe aortic stenosis and
preserved ejection fraction has been debated. The aim of the present study was to evaluate the effect of aortic
valve intervention on survival in that group.
Methods: A cohort of 416 consecutive patients with low gradient severe aortic stenosis (aortic valve area,
1 cm2; mean pressure gradient,<40 mm Hg) and preserved ejection fraction (50%) were identified from
the Sheba Medical Center echocardiography database. Clinical data, aortic valve intervention, and death
were recorded.
Results:During an average follow-up of 28 months, of 416 study patients (mean age, 76 14 years, 42%men),
97 (23%) underwent aortic valve intervention and 140 (32%) died. Mantel-Byar analysis showed that the
cumulative probability of survival was significantly greater after aortic valve intervention. Multivariate
analysis revealed a 49% reduction in the risk of death after surgery (P<.05). The survival benefit of aortic valve
intervention was comparable with adjustment to older age, aortic valve area 0.8 cm2, and a low (35 cm2/m2)
or normal (>35 cm2/m2) stroke volume index.
Conclusions: Our findings suggest that aortic valve intervention is associated with improved survival among pa-
tients with low gradient severe aortic stenosis and preserved left ventricular function. The presence of either a low
or normal stroke volume index did not affect the mortality benefit. (J Thorac Cardiovasc Surg 2014;148:2823-8)See related commentary on pages 2828-9.
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C
DSevere aortic stenosis (AS) is a common valvular disease
defined as a calculated aortic valve area (AVA) 1 cm2
and a mean pressure gradient of 40 mm Hg.1,2 However,
30% of patients with AS and a preserved (50%)
ejection fraction (EF) might have the inconsistent results
of a reduced AVA (1.0 cm2) and a lower than expected
transvalvular gradient (<40 mm Hg).3-5 Previous studies
have differentiated these patient populations into those
with either a low transvalvular flow (define as a stroke
volume index [SVI] of 35 mL/m2) or normal flow (NF).
Accordingly, 4 groups of patients with severe AS and
preserved EF were described: patients with NF and a high
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The Journal of Thoracic and Car(NF/LG), patients with low flow and a HG (LF/HG), and
patients with LF and a LG (LF/LG).6 Agreement has been
reached on the survival benefit of aortic valve replacement
(AVR) for symptomatic patients with HG (LF or HF) severe
AS. Nevertheless, data have been conflicting regarding the
effect of aortic intervention for patients with LG severe
AS and preserved EF.3,7-13 Studies have mostly shown that
patients with LF/LG severe AS and preserved EF will fare
better when referred for AVR.3,6-8,10-12 However, the
results from 1 study suggested that patients with LG/LF
severe AS and a normal EF will have outcomes similar to
those of patients with moderate AS and that AVR had no
significant prognostic effect among these patients.9 The
aim of the present study was to evaluate the effect of aortic
valve intervention (either surgical or transcatheter aortic
valve placement) on survival among patients with LG severe
AS and a preserved EF, and whether this was influenced by
the presence of either a normal or decreased SVI (NF/LF).METHODS
Patient Population
Echocardiographic and Doppler studies of patients with severe AS
and preserved LVEF were retrospectively reviewed from the Sheba
Medical Center echocardiography database from 2004 to 2012.
The inclusion criteria were AVA  1 cm2, mean aortic valve pressure
gradient< 40 mm Hg, and EF  50% (ie, patients with LG severe AS
with NF or LF). The exclusion criterion was any other significant valvular
disease, defined as any moderate or moderate to severe valvular disease.
The institutional review board approved the present study.diovascular Surgery c Volume 148, Number 6 2823
Abbreviations and Acronyms
AS ¼ aortic stenosis
AVA ¼ aortic valve area
AVR ¼ aortic valve replacement
BSA ¼ body surface area
CI ¼ confidence interval
EF ¼ ejection fraction
HG ¼ high gradient
HR ¼ hazard ratio
LF ¼ low flow
LG ¼ low gradient
LV ¼ left ventricular
LVOT ¼ left ventricular outflow tract
NF ¼ normal flow
SVI ¼ stroke volume index
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DStandard Echocardiographic and Doppler
Measurements
Two-dimensional transthoracic echocardiographic and Doppler studies
were obtained with clinical ultrasound machines equipped with 3.5-MHz
transducers using standard views. The studies were digitally stored
(McKesson’s Horizon Cardiology Medical Software, Tel Aviv, Israel).
The parasternal long-axis view was used to measure the aortic annulus
diameter in early systole. Pulsed Doppler in the left ventricular (LV)
outflow tract (LVOT) from the apical window allowed us to evaluate the
flow. A continuous wave Doppler recording of the flow through the aortic
valve was performed from the apical, right parasternal, suprasternal, and
subcostal windows to minimize the effect of Doppler angulation with
flow. The LV stroke volume was derived using the time velocity interval
of the LVOT, assuming a circular geometry of the LVOT. The indexed
stroke volume was calculated as the stroke volume divided by the body
surface area (BSA). Multiplying the heart rate by the stroke volume
allowed us to calculate the cardiac output; the cardiac output indexed to
the BSA was also calculated. The AVA was derived from the continuity
equation. The indexed AVA to BSA was calculated as the AVA divided
by the BSA. Using the continuous wave jet recording, the peak and
mean velocity were measured. The peak velocity was derived from the
Bernoulli equation, and the mean gradient represents the integral of the
maximal velocities acquired throughout all of systole. The LVEF was
estimated by the reader.
Clinical Data
The clinical data were obtained from the Sheba Medical Center
computerized patient records. The data included age, gender, BSA, body
mass index, a history of smoking, hypertension, hyperlipidemia, diabetesmel-
litus, renal failure, coronary heart disease, and cerebrovascular disease. Com-
plete clinicaldatawere available for 87%of the studypopulation. Intervention
wasdefinedaseither surgical or transcatheterAVR.Thedecision regarding the
choice of aortic valve intervention was made by the treating cardiologist. The
decision of transcatheter aortic valve intervention was made by a heart team
for patients with prohibitive risk. Mortality was evaluated using the Israeli
Ministry of Interior National Registry and was confirmed in all patients; the
cause of death was not available.
Statistical Analysis
The study population was divided into 2 groups (intervention vs medical
treatment). The Student t test was used to compare continuous variables,
and Fischer’s exact test was used to compare dichotomous variables2824 The Journal of Thoracic and Cardiovascular Surbetween the 2 groups. The benefit of aortic intervention on the estimated
survival was compared, as previously described by Mantel and Byar.14
In brief, all subjects began treatment in the conservative treatment group.
The subjects who underwent aortic valve intervention were entered
into the intervention group on the day of surgery and remained in the
intervention group until death or censoring. The patients in the conservative
treatment group remained in the no intervention group during the follow-up
period. Univariate and multivariate Cox proportional hazards models were
used to calculate the hazard ratio (HR) for the time-dependent surgical
intervention for survival. The multivariate model included adjustment for
age, gender, ischemic heart disease, body mass index, AVA (0.8 cm2),
and aortic valve intervention as a time-dependent covariate. In addition,
a propensity score model for the decision to perform aortic valve
intervention was calculated for all subjects with available clinical data.
The model included age gender, body mass index, mean aortic valve
gradient, peak aortic valve velocity, AVA, LVEF, ischemic heart disease,
and diabetes mellitus. The propensity score was then entered into the
Cox regression analysis of long-term survival. Statistical significance
was accepted for a 2-sided P<.05. The statistical analyses were performed
using IBM SPSS, version 20.0 (IBM, Armonk, NY).
RESULTS
A total of 416 patientswere identified (age, 76 14 years;
42%men; Table 1) with LG severe AS and a preserved EF.
The study population was divided into those with (91 surgi-
cal AVR, 6 transcatheter aortic valve placement) and
without aortic valve intervention. The baseline characteris-
tics of the study population are listed in Table 1; the groups
were similar, although the patients referred for aortic valve
intervention were significantly younger. The patients’ echo-
cardiographic parameters are listed in Table 2. LV function
was comparable in both groups. In contrast to the medical
group, the intervention group was characterized by a larger
LVmass, higher gradients, a higher SVI, and a reducedAVA.
Of the 416 patients, 303 had NF and 113 had LF. The LF
group had a significantly greater BSA (1.9  0.2 vs 1.8 
0.2 m2) and body mass index (30  6 vs 27  6 kg/m2).
The LV dimensions and mass were comparable between
the 2 groups, and the Doppler parameters revealed a signif-
icantly lower peak velocity (3.4  0.4 vs 3.67 m/s), mean
gradient (27  7.5 vs 31.4  0.6 mm Hg), stroke volume
(57.6 vs 74.1 mL), cardiac index (2.5 vs 3.1 L/min/m2),
and EF (58.8% vs 60.1%) in the LF group.
Aortic Intervention and Survival
During the follow-up period (28  25 months),
143 patients (32%) died. The 30-day mortality rate for
the patients who underwent surgical or transcatheter aortic
intervention was 16% (n ¼ 15). The average follow-up
period until aortic valve intervention was 11.3  16.4
months. Mantel-Byar curve analysis revealed a significantly
greater cumulative probability of survival after AVR
(P ¼ .001; Figure 1). Consistently, multivariate analysis
showed that time-dependent AVR was associated with a
49% reduction in the risk of death (P< .05; Table 3).
A similar reduction in the risk of death was obtained
when a propensity score for the decision to perform aorticgery c December 2014
TABLE 1. Baseline characteristics
Parameter All (n ¼ 416)
Aortic valve intervention
No (n ¼ 319) Yes (n ¼ 97)
Male gender 174 (42) 126 (40) 48 (50)
Age (y) 76  14 78.6  10.5* 73.3  11
Age>80 y 199 (48) 173 (54)* 26 (27)
Body mass index (kg/m2) 28.1  5.2 28  5.5 28.1  4.3
Body surface area (m2) 1.8  0.2 1.8  0.2 1.8  0.2
Diabetes mellitus 132 (32) 92 (35) 40 (41)
Hypertension 246 (59) 183 (69) 63 (65)
Dyslipidemia 178 (43) 132 (50) 46 (47)
Active smoker 22 (5) 17 (6) 5 (5)
Chronic renal failure 83 (20) 67 (25) 16 (17)
Ischemic heart disease 166 (40) 122 (46) 44 (45)
Cerebrovascular disease 66 (16) 52 (20) 14 (14)
Data presented as n (%) or mean  standard deviation. *P<.05 versus aortic valve
intervention.









EF (%) 60  5 60  5 59  5
LV diastolic dimension (cm) 4.6  0.5 4.5  0.5* 4.7  0.5
LV systolic dimension (cm) 2.7  0.5 2.7  0.5* 2.8  0.6
Septum width (cm) 1.2  0.2 1.2  0.2 1.2  0.2
Posterior wall thickness (cm) 1.1  0.2 1.1  0.2 1.1  0.2
LV mass (g) 193  47.6 190  46* 202.9  51.5
LV mass index (g/m2) 107.7  24.4 106.3  23.8 112.3  26.1
LVOT diameter (cm) 2  0.1 2  0.1 2  0.1
Stroke volume (mL) 69.7  12.1 68.8  12.3 72.3  11.2
Stroke volume index (mL/m2) 39.1  7 38.7  7.2* 40.3  6.2
Cardiac index (L/min/m2) 2.7  0.5 2.7  0.5 2.7  0.5
AVA (cm2) 0.83  0.1 0.83  0.1* 0.81  0.1
Indexed AVA (cm2) 0.46  0.1 0.47  0.1* 0.45  0.1
Aortic valve mean gradient
(mm Hg)
30.5  6.3 30  6.5* 32.1  5.3
Aortic valve peak gradient
(mm Hg)
52.4  11.4 51.4  11.4* 55.8  10.8
Peak velocity (m/s) 3.6  0.4 3.5  0.4* 3.7  0.4
LA area (cm2) 22.9  7 23.2  7.6* 21.9  4.3
Pulmonary systolic arterial
pressure (mm Hg)
40.1  11.9 40.6  11.9 38.5  11.9
Data presented as mean  standard deviation. EF, Ejection fraction; LV, left
ventricular; LVOT, LV outflow tract; AVA, aortic valve area; LA, left atrial. *P<.05
versus aortic valve intervention.
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Dvalve intervention was entered as a covariate in to the Cox
regression model (HR, 0.54; 95% confidence interval [CI],
0.29-0.98; P< .05). In addition, comparable results were
noted after the exclusion of 6 patients who had undergone
transcatheter AVR (HR, 0.34; 95% CI, 0.17-0.68; P<.05).
Older age (>80 years) and a reduced AVA (0.8 cm2)
were associated with a significant increase in the risk of
death (HR, 4.7 and 1.7 respectively; P< .05). The effect
of intervention on the cumulative survival rate was further
analyzed in 3 different subgroups (Figure 2). Aortic valve
intervention had a similar positive effect on survival in
the LF and NF (SVI  35 vs>35 mL/m2) subgroup, older
age subgroup, and in the subgroup with the cutoff AVA
value decreased from 1 to 0.8 cm2 (Figure 2). Univariate
Cox regression subanalysis of patients who underwent
aortic valve intervention showed that the indexed AVA did
not affect survival (HR, 0.977; 95% CI, 0.896-1.065;
P ¼ .599). Similar results were obtained in a multivariate
Cox regression model that included an adjustment for age
and gender (HR, 0.969; 95% CI, 0.893-1.051; P ¼ .448).DISCUSSION
The results from the present study have demonstrated that
aortic valve intervention improves the prognosis of patients
with LG severe AS and a preserved EF. The mortality
benefit was seen in those with either a normal or decreased
SVI, older patients, and those with a reduced AVA
(0.8 cm2). A consistent positive effect of aortic valve
intervention was noted when a propensity score was entered
as a covariate in the Cox regression model.Diagnosis of LG Severe AS With Preserved EF
The evaluation of patients with inconsistency in the
aortic valve gradient and calculated AVA is challenging.
This is emphasized in the presence of normal LV function.
Awareness of the echocardiographic pitfalls is important,The Journal of Thoracic and Carespecially with the use of the continuity equation because
errors in measuring the LVOT diameter, the assumption of
a circular LVOT, and error in tracing the velocity time
interval could occur. Doppler angle dependency could
also explain the reduced valve gradient. These echocardio-
graphic challenges and recognition of the term ‘‘paradoxi-
cal LF LG severe AS’’ (defined as an SVI of 35 mL/m2)
have led to an increased interest in the entity of LG severe
AS. Patients with LF LG severe AS were reported to be
older, more often female, and to have a greater incidence
of hypertension. The heart was reported to have concentric
LV remodeling, a greater degree of myocardial fibrosis, and
a smaller cavity, which can preserve myocardial contrac-
tility with a reduced cardiac output.3,6,7,15,16 The 2012
European Society of Cardiology guidelines for managing
valvular heart disease have recommended AVR (level IIa
recommendation) for those patients but only after careful
confirmation of severe AS.1 The authors of the guidelines
would emphasize the diagnostic difficulty and also raise
the option that some patients in that group might actually
have moderate AS. The inconsistency between gradients
and the AVA could also have been secondary to an AVA
cutoff of 1 cm2 (in contrast to 0.8 cm2), which was also
discussed in an editorial by Zoghbi17 and mentioned by
Pibarot and Dumesnil.18 Thus, we studied the effect of
AVR in a large cohort of patients with LG severe AS. The
large cohort allowed us to explore the prognostic effect ofdiovascular Surgery c Volume 148, Number 6 2825
FIGURE 1. Mantle-Byar survival curve of the study population demonstrating that aortic valve intervention was associated with better survival (P<.05).
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C
Daortic valve intervention on subgroups stratified by LF and
NF or a reduced AVA (0.8 cm2).
Prognosis of LG Severe AS
Several studies have evaluated the prognosis of patients
with LF, LG severe AS and a preserved EF and showed
reduced overall survival. Although the perioperative
mortality was increased, AVR was associated with
improved survival.3,6,7,10-13,19-21 However, Jander and
colleagues9 reported outcomes similar to those of patients
with moderate AS, with no difference between those with
LF and NF. The prognosis was similar in the medically
and surgically treated patients. In the present study, AVR
was associated with a better prognosis, regardless of the
presence of NF or LF, consistent with previous reports by
Hachicha and colleagues3 and Ozkan and colleagues.22
Recent data regarding LG, NF severe AS are worth
discussion. Eleid and colleagues20 have revealed that
patients with NF and LG severe AS did not benefit from
AVR. In contrast, Mehrotra and colleagues23 showed that
those patients had a prognosis similar to those withTABLE 3. Multivariate Cox regression analysis
Parameter HR 95% CI P value
Male gender 1.1 0.7-1.5 .8
Age>80 y 4.7 3.1-7.2 <.001
Aortic valve area  0.8 cm2 1.7 1.1-2.4 <.05
Body mass index (kg/m2) 1 1-1.1 .3
Ischemic heart disease 1.2 0.8-1.8 .3
Aortic valve replacement 0.51 0.3-0.9 <.05
HR, Hazard ratio; CI, confidence interval.
2826 The Journal of Thoracic and Cardiovascular Surmoderate AS. Studying asymptomatic patients with LG
and NF severe AS, Lancellotti and colleageus21 has shown
better survival for those patients, although the group of
patients was small. In contrast, Mohty and colleagues,13
in a cardiac catheterization study of symptomatic patients,
have shown reduced long-term survival and improved
survival with AVR, although these were high-risk patients.
These conflicting reports were mentioned in an editorial
by Pibarot and Dumesnil.18 The heterogeneity of NF LG
severe AS was discussed; some patients could actually
have had moderate AS because of the inconsistency in
aortic valve grading related to the guidelines criteria,
already stated in our report. Another group of patients might
have a small body size, such that the AVA might be<1 cm2
but the index valve area would be>0.6 cm2; thus, these
patients should be treated as having moderate AS. The
inconsistency in the prognosis seen among studies can be
explained by the inconsistency in the definition of severe
AS. Studies that defined severe AS by an indexed AVA of
<0.6 cm2 have succeeded in showing a prognostic effect
of AVR.17,23 In the present study, all patients had an AVA
of<1 cm2 with an indexed AVA of<0.6 cm2, supporting
the positive effect on survival of AVR in patients with
true NF, LG severe AS. Moreover, the positive effect of
aortic valve intervention was noted in both patients with
an AVA of<0.8 cm2 and>0.8 cm2. The importance of
our findings are even more emphasized by the database
characteristics: our database included data from an older
population (age, 76  14 years) with a high prevalence of
other comorbidities (59% hypertension, 32% diabetes
mellitus, 40% coronary artery disease, 20% chronic renalgery c December 2014
FIGURE 2. Effect of aortic valve intervention on the cumulative survival
rate in the subgroups. A positive effect for aortic valve intervention was
seen in all 3 subgroups: low flow versus normal flow (a stroke volume index
[SVI] of<35 vs>35 mL/m2), older age (>80 vs<80 years), and an aortic
valve area (AVA) cutoff of 0.8 cm2 versus 1 cm2.
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who were less likely to have undergone aortic valve
intervention and had a worse prognosis, had improved
survival with intervention, emphasizing the importance
of intervention, especially in a high-risk population.
In general, our analysis has supported intervention for
patients with LG severe AS, regardless of the other clinical
or echocardiographic parameters.
Study Limitations
This was a retrospective, single-center analysis, and
decisions on medical or surgical intervention were at theThe Journal of Thoracic and Cardiscretion of the treating physician. We did not have access
to those records. Data regarding symptoms, pharmacologic
treatment, and functional class at the baseline echocardio-
graphic examination and the surgical findings and
perioperative complications were not available. Because
our institution is a tertiary referral center, with a
large-volume cardiothoracic surgical department, we
believe our data might have been bias by a high frequency
of symptomatic patients who were referred for aortic valve
intervention, although we did not have a high percentage of
aortic valve intervention. The entity of LF, LG severe AS
was introduced during the study period; thus, the treatment
strategy might have changed. We reported all-cause
mortality only, because the cause of death was not available
from the Israeli Ministry of Interior National Registry.
The blood pressure was not documented for all patients
during the echocardiographic examination; therefore,
valvuloarterial impedance was not included in our analysis.
The LV contractile reserve and energy loss index were also
not reported. The EF was visually estimated by the reader
and was not evaluated using a quantitative method.
Previous studies have shown a good correlation between
the visually estimated EF and the calculated EF. The
AVA was calculated using continuity equations, where
errors might occur. Eleid and colleagues20 have shown a
good correlation between echocardiography and cardiac
catheterization in calculating the AVA in patients with LG
severe AS.
CONCLUSIONS
The present study has shown that aortic valve
intervention will be associated with improved survival for
patients with LG severe AS and a preserved EF. This
positive effect was noted in patients with both LF and NF,
emphasizing the importance of recognizing this entity and
early referral for surgical AVR.
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stenosis. Eur Heart J. 2013;34:1906-14.MMENTARYLow-gradient severe aortic stenosis also benefits from aortic valve
replacementCarlos A. Mestres, MD, PhD, FETCSAortic stenosis (AS) is a surgical disease, and patients are
best treated with valve replacement at any age and condi-
tion, as it has been well documented over time.1-3 Theresults of the study of transcatheter versus surgical aortic
valve replacement (SAVR) in high-risk patients correspond-
ing to the Placement of Aortic Transcatheter Valves (PART-
NER) trial published in 2011 suggested that in high-risk
patients with severe AS, transcatheter and surgical proce-
dures for AVR were associated with similar survival at 1
year, although there were important differences in peripro-
cedural risks.4 This was despite a number of well-
acknowledged limitations, such as the noninferiority
design, frequent unexpected withdrawals, and lack of statis-
tical power for robust conclusions in specific subgroups of
patients. It is expected that technologic advancement will
improve outcomes if current procedural and postprocedural
limitations are overcome and some indications clearly
defined.5-7 At this time, SAVR and transcatheter valve
implantation are treatment options covering almost all
possible groups of patients requiring an aggressive
treatment of AS; however, there are still some doubts ongery c December 2014
